SEC Form 4 · accession 0001140361-15-013288
Raptor Pharmaceutical Corp · RPTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond Anderson
Director
Period of report
Mar 24, 2015
Accepted (ET)
Mar 26, 2015 · 9:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070698
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F3 | Mar 24, 2015 | M | 11,313 | $2.57 | A | 12,987 | D | |
| Common StockF1,F3 | Mar 24, 2015 | M | 8,306 | $2.57 | A | 21,293 | D | |
| Common StockF1,F3 | Mar 24, 2015 | M | 2,000 | $2.02 | A | 23,293 | D | |
| Common StockF1,F3 | Mar 24, 2015 | S | 21,619 | $12.00 | D | 1,674 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock options (right to buy)F1,F2 | $2.57 | Mar 24, 2015 | M | 11,313 | D | — | Jun 14, 2017 | Common Stock | 11,313 | 0 | D |
| Stock options (right to buy)F1,F2 | $2.57 | Mar 24, 2015 | M | 8,306 | D | — | May 26, 2016 | Common Stock | 8,306 | 0 | D |
| Stock options (right to buy)F1,F2 | $2.02 | Mar 24, 2015 | M | 2,000 | D | — | Mar 9, 2020 | Common Stock | 2,000 | 13,000 | D |
Explanation of responses
- F1Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 21, 2014.
- F2Fully vested and exercisable.
- F3Includes 1674 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to one (1) share of common stock for each one (1) RSU upon the vesting thereof.